Paediatric formulation of fosamprenavir approved in Europe

On 13 September, the EMEA issued a decision to extend the indication for fosamprenavir (Telzir) in combination with ritonavir to include adolescents and children of six years and older.

Telzir – EMEA European Public Assessment Report (includes full prescribing information)
Telzir – EMEA scientific opinion for approval PDF

Source: GSK press release.

Links to other websites are current at date of posting but not maintained.